High-grade glioma in children and adolescents: a single-center experience
- 17 December 2015
- journal article
- Published by Springer Nature in Child's Nervous System
- Vol. 32 (2) , 291-297
Abstract
The aim of this study was to report the outcome in children with high-grade astrocytoma outside the brain stem and spinal cord that were treated at a single center. The study included 26 patients with anaplastic astrocytoma and 37 patients with glioblastoma; all patients were aged ≤18 years. At initial diagnosis, 18 of the patients with glioblastoma received only temozolomide (TMZ), 14 received other chemotherapies, and 5 did not receive any chemotherapy. Among the patients with anaplastic astrocytoma, 9 received TMZ, 9 received other chemotherapy regimens, and 8 patients did not receive any chemotherapy. The median radiotherapy dose in all patients was 60 Gy. Median age of the patients was 12.5 years. Median overall survival was 20 months and mean progression-free survival was 4.7–11.3 months (median: 8 months) in all patients. Patients with a Karnofsky performance score (KPS) ≥70 had median overall survival of 32 months, versus 7 months in those with a KPS < 70. Patients aged P = 0.493). Although TMZ is less toxic than PCV, it was not shown to be superior.Keywords
This publication has 16 references indexed in Scilit:
- Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcomeChild's Nervous System, 2012
- Pediatric glioblastoma multiforme: A single-institution experienceIndian Journal of Medical and Paediatric Oncology, 2012
- Glioblastoma in Children: A Single-Institution ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology GroupNeuro-Oncology, 2011
- Intensive chemotherapy improves survival in pediatric high‐grade glioma after gross total resection: results of the HIT‐GBM‐C protocolCancer, 2009
- Glioblastoma multiforme in children: experience at Hospital Infantil de Mexico Federico GomezChild's Nervous System, 2009
- Epidemiology of brain tumors in childhood—a reviewToxicology and Applied Pharmacology, 2004
- The WHO Classification of Tumors of the Nervous SystemJournal of Neuropathology & Experimental Neurology, 2002
- Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: Report from the Children's Cancer GroupMedical and Pediatric Oncology, 1999
- The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trialJournal of Neuro-Oncology, 1989